Lv5
1240 积分 2023-10-29 加入
Kaposi sarcoma
4小时前
待确认
Placebo responses in randomized controlled trials for systemic therapy in atopic dermatitis: A systematic review and meta-analysis
1天前
待确认
Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial
1天前
待确认
Placebo response in phase 2 and 3 trials of systemic and biological therapies for atopic dermatitis—a systematic review and meta‐analysis
3天前
已完结
Unlocking the potential: advancements and future horizons in ROR1-targeted cancer therapies
1个月前
已完结
Efficacy and safety of rocatinlimab for the treatment of moderate-to-severe atopic dermatitis in ROCKET-IGNITE and ROCKET-HORIZON: two global, double-blind, placebo-controlled, randomised phase 3 clinical trials
1个月前
已完结
Bispecific and multispecific antibodies in oncology: opportunities and challenges
2个月前
已完结
First-line sacituzumab tirumotecan with tagitanlimab in advanced non-small-cell lung cancer: a phase 2 trial
3个月前
已完结
Modulating Treg stability to improve cancer immunotherapy
5个月前
已完结
Hyperprogressive disease: recognizing a novel pattern to improve patient management
5个月前
已完结
皖公网安备34019202002308
